Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-963-1 | CAS number: 90-04-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 23 FEB 2010 to 10 MAR 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (OECD 429)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- o-anisidine
- EC Number:
- 201-963-1
- EC Name:
- o-anisidine
- Cas Number:
- 90-04-0
- Molecular formula:
- C7H9NO
- IUPAC Name:
- 2-methoxyaniline
- Details on test material:
- - Name of test material (as cited in study report): o-Anisidine
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Postbus 6174, 5960 AD Horst / The Netherlands
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 15 - 25 g
- Housing:single caging
- Diet (e.g. ad libitum): pelleted standard diet (Harlan Laboratories GmbH, 33178 Borchen), ad libidum
- Water (e.g. ad libitum): tap water, (Gemeindewerke, 64380 Rossdorf), ad libitum
- Acclimation period: At least 5 days prior to the start of dosing under test conditions after health examination. Only animals without any visible signs of illness will be used for the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + 2°C
- Humidity (%): 45-65%
- Photoperiod (hrs dark / hrs light): artificial light 6:00 a.m. - 6:00 p.m.
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 25, 50, and 100%
- No. of animals per dose:
- 4
- Details on study design:
- In order to study a possible allergenic potential of o-Anisidine, three groups each of four female mice were treated with different concentrations of the test item by topical application at the dorsum of each ear (left and right) on three consecutive days. A control group of four mice was treated with the vehicle only. Five days after the first topical application, the mice were intravenously injected into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed and the draining auricular lymph nodes were excised and pooled per group. Furthermore, after the lymph nodes had been excised, both ears of the mice were punched at the apical area using a biopsy punch (Ø 8 mm corresponding to 0.5 square cm) and were immediately weighed pooled per animal using an analytical balance. Single cell suspensions of lymph node cells were prepared from lymph nodes pooled per group, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a beta-scintillation counter.
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables.
The EC3 value was calculated according to the equation
EC3 = (a-c) [(3-d)/(b-d)] + c
where EC3 is the estimated concentration of the test item required to produce a 3-fold increase in draining lymph node cell proliferative activity; (a, b) and (c, d) are respectively the co-ordinates of the two pair of data lying immediately above and below the S.I. value of 3 on the local lymph node assay dose response plot.
A statistical analysis was performed for the values obtained for the ear weights to assess whether the difference is statistically significant between test item groups and the negative control (vehicle) group and also to assess if there is a dose response relationship.
However, both biological and statistical significance were considered together.
Results and discussion
- Positive control results:
- Experiment performend in November 2009, 5, 10, and 25% alpha-Hexylcinnamaldehyde yielded a S.I. of 1.78, 2.54, and 4.88, respectively. The EC3 value calculated was 12.9%
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: 25% test item: 2.26 50% test item: 3.43 100% test item: 1.27
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: DPM per lymph node: control: 528.5 25% test item: 1193.0 50% test item: 1813.1 100% test item: 672.2
Any other information on results incl. tables
Test item concentration % |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
19 |
--- |
--- |
--- |
--- |
--- |
BG II |
19 |
--- |
--- |
--- |
--- |
0 |
1 |
4247 |
4228 |
8 |
528.5 |
|
25 |
2 |
9563 |
9544 |
8 |
1193.0 |
2.26 |
50 |
3 |
14524 |
14505 |
8 |
1813.1 |
3.43 |
100 |
4 |
4052 |
4033 |
6 |
672.2 |
1.27 |
BG=Background (1 ml 5% trichloroacetic acid) in duplicate 1=Control Group 2-4=Test Group S.I.=Stimulation Index
a)=The mean value was taken from the figures BG I and BG II b)=Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled
|
Test item concentration % |
S.I. |
Test Group 2 |
25 (a) |
2.26 (b) |
Test Group 3 |
50 (c) |
3.43 (d) |
EC3 = (a-c) [(3-d)/(b-d)] + c =40.8%(w/v) |
EC3 = Estimated concentration for a S.I. of 3. a,b,c,d = Co-ordinates of the two pairs of data lying immediately above and below the S.I. value of 3 on the LLNA dose response plot.
Viability / Mortalit
One animal of the group treated with the undiluted test item (100%) was found dead 24 hours after the second application.
Clinical Signs
No symptoms of local toxicity at the ears of the animals and no systemic findings were observed during the study period.
Body Weights
The body weight of the animals, recorded prior to the first application and prior to treatment with3HTdR, was within the range commonly recorded for animals of this strain and age.
Ear Weights
The measured ear weights of all animals treated were recorded after necropsy. A statistically significant increase in ear weights was observed for the animals belonging to the group treated with a test item concentration of 50% in comparison to the control (vehicle) group (p=0.018).
Ear biopsy (punches ofØ8 mm corresponding to 0.5 cm2) |
|||||
Animal No |
Dose Group |
Ear weights ( two ears per animal, one punch per ear in mg) |
Mean |
Standard deviation |
|
1 |
1 |
19.95 |
22.96 |
2.30 |
|
2 |
1 |
23.01 |
|||
3 |
1 |
23.33 |
|||
4 |
1 |
25.54 |
|||
5 |
2 |
23.68 |
25.08 |
1.06 |
|
6 |
2 |
24.84 |
|||
7 |
2 |
25.85 |
|||
8 |
2 |
25.95 |
|||
9 |
3 |
32.57 |
29.98* |
3.16 |
|
10 |
3 |
32.85 |
|||
11 |
3 |
27.32 |
|||
12 |
3 |
27.17 |
|||
13 |
4 |
23.75 |
24.23 |
0.59 |
|
14 |
4 |
animal died |
|||
15 |
4 |
24.89 |
|||
16 |
4 |
24.04 |
1 = Control Group 2-4 = Test Groups * = statistically significant
Applicant's summary and conclusion
- Interpretation of results:
- other: equivocal
- Conclusions:
- Based on S.I. values one of which is slightly above 3, o-Anisidine would have to be regarded as a skin sensitiser. But due to missing dose response relationship, potentially irritating effects, and the impairment by an unexplained death of one animal this interpretation seems not to be entirely reliable. Thus the final conclusion is that the outcome of this study is considered to be equivocal. Further evidence regarding the question whether the obtained effect is truly of a sensitising nature or not can only be obtained using further appropriate studies.
- Executive summary:
The present study analyses the sensitising potential of o-anisidine.
Three groups each of four female mice were treated daily with the test item at concentrations of 25% (v/v), 50% (w/v), and 100% (undiluted test item) in dimethylsulfoxide by topical application to the dorsum of each ear (left and right) for three consecutive days. A control group of four mice was treated with the vehicle (dimethylsulfoxide) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes, which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a beta-scintillation counter.
Clinical signs of systemic toxicity were not observed in the animals treated with different concentrations of the test item. However, one animal of the group treated with the undiluted test item (100%) was found dead 24 hours after the second application.
No signs of local irritation (e.g. ear swelling, reddening of the ear skin) were observed in the treated animals over the whole study period. However, a statistically significant increase in ear weights was obtained for the animals belonging to the group treated with a test item concentration of 50% in comparison to the control (vehicle) group (p=0.018).
A test item is regarded as a sensitiser in the LLNA if the exposure to one or more test concentration resulted in 3-fold or greater increase in incorporation of3HTdR compared with concurrent controls, as indicated by the Stimulation Index (S.I.). The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.
In this study Stimulation Indices of 2.26, 3.43, and 1.27 were determined with the test item at concentrations of 25, 50, and 100% in dimethylsulfoxide demonstrating slight excedance of threshold for one concentration but no clear dose response relationship. The S.I. for the high dose group was derived from 3 animals only due to the fact that one animal belonging to this group died. The decrease in S.I. seen at this concentration as compared to the lower doses might be related to systemic effects of the test item. The EC3 value in terms of figures was 40.8 % (w/v). However, it cannot be excluded that skin irritating properties of the test item may have contributed to the increase in lymph node cell proliferation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.